Global LEI Index
无锡药明康德新药开发股份有限公司
Official identifier 254900OEPQLZSPLN9175
Global
LEI record
- LEI status
- Issued
Entity identity
- Legal jurisdiction
- China
- Legal form
- Source legal-form code: ECAK
- Entity status
- Active
Official registration identifier
- Registration authority
- National Enterprise Credit Information Publicity System (RA000092)
- Registered entity identifier
- 91320200724183068U
Dates
- Initial registration date
- 4 Dec 2018
- Next renewal date
- 7 Sep 2027
Reported accounting relationships
These are relationships reported for accounting consolidation; they do not establish legal ownership.
Page 1 of 1 · 2 reported relationships.
- STA PHARMACEUTICAL HONG KONG INVESTMENT LIMITED — Ultimate accounting consolidation parent — 无锡药明康德新药开发股份有限公司; status Active
- 合全药业香港有限公司 — Ultimate accounting consolidation parent — 无锡药明康德新药开发股份有限公司; status Active
Reporting exceptions
- Direct accounting consolidation parent · Parent is not subject to accounting consolidation
- Ultimate accounting consolidation parent · Parent is not subject to accounting consolidation
These are source-reported exceptions to accounting-relationship reporting. They do not establish ownership or the absence of an owner.
This record is not linked to a company profile on Grayperson.
Source
Source: GLEIF Golden Copy.
Registration authority: National Enterprise Credit Information Publicity System (RA000092).